953771-32-9

Basic information

• Product Name: N-(cyclohexylmethyl)-6-methoxybenzo[d]thiazol-2-amine
• Synonyms: N-(cyclohexylmethyl)-6-methoxybenzo[d]thiazol-2-amine
• CAS NO: 953771-32-9
• Molecular Weight: 276.403
• Mol File: 953771-32-9.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: N-(cyclohexylmethyl)-6-methoxybenzo[d]thiazol-2-amine(CAS DataBase Reference)
• NIST Chemistry Reference: N-(cyclohexylmethyl)-6-methoxybenzo[d]thiazol-2-amine(953771-32-9)
• EPA Substance Registry System: N-(cyclohexylmethyl)-6-methoxybenzo[d]thiazol-2-amine(953771-32-9)

Safety Data

• Hazardous Substances Data: 953771-32-9(Hazardous Substances Data)

Upstream product

• 2605-14-3 2-chloro-6-(methyloxy)-1,3-benzothiazole 
• 3218-02-8 cyclohexylmethylamine 

Downstream Products

• 953771-34-1 2-(cyclohexylmethylamino)benzo[d]thiazol-6-ol 

Relevant articles and documents

6-O-SUBSTITUTED BENZOXAZOLE AND BENZOTHIAZOLE COMPOUNDS AND METHODS OF INHIBITING CSF-1R SIGNALING

Benzoxazole and benzothiazole compounds and the stereoisomers, tautomers, solvates, oxides, esters, and prodrugs thereof and pharmaceutically acceptable salts thereof are disclosed. Compositions of the compounds, either alone or in combination with at least one additional therapeutic agent, with a pharmaceutically acceptable carrier, and uses of the compounds, either alone or in combination with at least one additional therapeutic agent are also disclosed. The embodiments are useful for inhibiting cellular proliferation, inhibiting the growth and/or metathesis of tumors, treating or preventing cancer, treating or preventing degenerating bone diseases such as rheumatoid arthritis, and/or inhibiting molecules such as CSF-1R.